Drug Profile
Research programme: cellspan organ implants - Harvard Apparatus Regenerative Technology/Mayo Clinic
Alternative Names: Cellspan bronchial implant; Cellspan tracheal implantLatest Information Update: 25 Jul 2023
Price :
$50
*
At a glance
- Originator Biostage
- Developer Harvard Apparatus Regenerative Technology; Mayo Clinic
- Class Stem cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer